For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
On October 8, Rep. Frank Pallone (D-NJ) introduced the Lower Premiums, Faster Payments Act as a fix for the disastrous No Surprises Act (NSA).
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Search Posts
Blog
Drug lag — precaution or pipelines?
According to a CNN Money article, a report released yesterday shows that the FDA has been cracking down on new drug approvals. Pharmaceutical companies…
Newsletter
CEI Daily Update
Issues in the News 1. HEALTH A pending bill in Congress would ban the use of genetic testing by insurance companies…
Newsletter
CEI Daily Update
Issues in the News 1. ENVIRONMENT NASA orders a review of climate data after an independent researcher discovers that 1934 – not 1998 as…
Blog
No Excuse for Resistance to DDT
Anti-DDT activists in the environmental movement often suggest we should stop using this chemical to save people from malaria and other diseases because mosquitoes will…
Newsletter
CEI Daily Update
Issues in the News 1. LEGAL Government officials in Nigeria attempt to sue drug maker Pfizer for $2 billion. CEI…
Blog
More on Bad Court Ruling Against Terminally Ill
“Terminally ill patients do not have a constitutional right to be treated with experimental drugs, even if they likely will be dead before the medicine…